P1101

· PharmaEssentia Japan K.K.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for P1101, covering 2022-01-27 to 2025-10-27. Get the full timeline:

Most recent: Clinical Trial Update: P1101 in Treating Patients With Myelofibrosis [Phase 2]